TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, poor responders to TKIs showed upregulation of TGF-β- and TNF-γ-pathway-associated genes that might be selectively targeted in CML-SCs, combined with a highly quiescent CML-SC signature.